Niox Share Discussion Threads

[edwardt] 30/4/2024 07:36

numis upgrade to buy today referencing the copd opportunity as a reason

[earwacks] 27/4/2024 14:19

Astra dissolved their partnership with Circassia over Tudorza and Duklar inhaler for COPD.Astra retained commercial rights in consideration of 150 million dollar debt and retained 18 percent of Circassia, now Niox. Astra have since offloaded this product. Not sure how successful it has been. Probably nothing like the FeNo tester. What Niox have is the development of the best Asthma diagnostic device and 600 million tax credit for the Circassia debacle. Meaning they will never pay tax on their very cash generative device. The tax credit is also transferable which makes it an added asset to their £270 million market cap. The directors are probably nearing retirement. They have built a highly profitable business from the wreckage of Circassia, making it a market leader in its field, but still only tapping 5 percent of possible world market. Added to that they are developing a domestic kit, which if successful will probably appeal to a us pharma giant, not necessarily just Astra, who as you say may not be interested as it is Gsk that have recently purchased a company that have developed an asthma drug. Potential for Niox is pretty big and are at an interesting stage where they might need some serious gearing up to reach potential global markets, whilst having converted themselves into a growing cash machine. Although expensive on last years results I don’t think forecasters have quite got their head around the potential of Niox yet

[rambutan2] 26/4/2024 19:54

Too lazy to dig back, but I'm sure Astra are there from some deal done year's ago under the previous, Woodford backed, management. Nothing to do with the current set up. Have prob forgotten they own the shares as it's such a piddling amount on their balance sheet.

[earwacks] 26/4/2024 18:13

Another 3 half million pound late reported buys this morning and forty bot trades of 2 or less shares drags the price back. No RNS for all these big trades this week.

[edwardt] 26/4/2024 16:35

Tam not ram!

[edwardt] 26/4/2024 16:35

Apparently Sanofi used feno in phase 3 trial of its copd drug - dupilumab with good data results. Now that is a good way to expand the ram for this company

[earwacks] 26/4/2024 15:23

Could be or should be? Surprised if they couldn’t determine other lung issues with their diagnostics. Wonder why Astrazenica don’t get on with buying them out before it gets any more expensive. Can’t be too difficult to determine growth potential of this company. The directors must be ready to put their feet up!

[edwardt] 26/4/2024 14:36

Could be used for copd....

[earwacks] 23/4/2024 11:10

Sp building with a £2 million purchase

[earwacks] 04/4/2024 14:18

Dividend announced for May/june. Possibly another special in the pipeline later according to broker Singer

[earwacks] 08/3/2024 08:51

Suspiciously active of late. Prelims still 2 weeks away

[earwacks] 23/2/2024 18:18

I think it’s held up well considering The uk is the worst performing market in the world and many British companies make most of their money in global business.
This is a recent high for NIOX. It is similar to share price movement last year between update and actual results. News on dividend and cash position should
help re establish the share price Then of course there is the expectant takeover by AZN Why else would they hold 16 percent of the. Company? Gl all

[thedudie] 23/2/2024 16:29

A better day than recent times ...heading higher into the results?

[jeanesy] 19/1/2024 15:39

shareprice has reached my stop loss so ive sold today. Can't see why its so weak but got to stick to my guns, lost too much money in the past not doing so. GLA

[earwacks] 18/1/2024 20:30

Lack of comments all round is strange. Nothing from Vox markets or Stockopedia who don’t seem to cover much other than retail and other odds and sods, certainly not medical or stuff in the ground. I guess it’s exactly in line from interims . Having doubled revenue from there to 36 million. Cash pile well ahead after payment of 10 million dividend. RG understandably trimmed his holding from 29 percent to 23 percent but Stanley came aboard for 5 percent in the high 60p’s. Appointment of financial advisor is interesting . Getting ready for takeover? Business model transition next year new generation of diagnostic kit in 2025 and development of home kit. All looks pretty impressive to me. Market is a bit nervy with all the troubles around actually holding up quite well thus far. Several Aim listed companies reporting strong results this months have received very Luke warm reaction from markets. Return of bull run still seems to be on hold for now. Gl

[jeanesy] 18/1/2024 14:50

results today and yet no comments? Should have followed the trend here and sold .. disappointing for several months now.

[earwacks] 10/1/2024 07:51

Niox would be the perfect complement in diagnosing severe asthma and managing the right level of treatment surely. FeNo being the gold standard in accurately measuring the exact inflammation of the airways

[p1nkfish] 09/1/2024 22:45

Noted the GSK addition to their asthma portfolio today.
I no longer hold NIOX but wish you all well.

[jeanesy] 02/1/2024 16:48

Trading statement due in a couple of weeks ?

[earwacks] 19/12/2023 06:03

Paul Hill catches up with GuyHarwood on his various funds. Brief mention of Niox and the home kit. Suggests they would need a partner to get this to retail. Well we know for a fact they have set aside money ( 2 million) for the home kit, and aside from that it sounds like the accelerating cash generation is set to continue with solid dividend cover. I listen with great interest to his other life science projects which all seem to need funding in some way at a very difficult time.
They have no tax to pay for yonks due to the unbelievable tax loss carry over of 600 million! So what are they going to do with the ever expanding cash pile?
Richard Griffiths still reducing gradually and still the largest holder. Clearly someone is happy to take them off his hands but maybe what has halted the rise of the share price for now. With the share price seemingly consolidating around this level looks a good opportunity to add.
As keen as I am to diversify, I just can’t see a better case for investing than here. I particularly like that they don’t really push this stock. They don’t need to, the numbers do the talking! Still up for a buy out but the sales will quickly catch up the premium rating PE of 22, not actually that expensive for a company with high teens revenue growth and great margins with recurring refill product. Gl

[thedudie] 30/11/2023 15:43

Look at the chart - falls in periods of no news and moves strongly up on continued good news. There is nothing to suggest this won't repeat in January on the release of the trading statement.

Recent statements suggest performance is strong and the company will end the year with significant cash even after paying the special dividend.

[earwacks] 30/11/2023 15:34

We are not likely to get any news till january, so was bound to drift. It does have a habit of lurching up, although the trend is clearly down. As I say, that is due to lack of news probably. Some enormous trades today. Hard to say if Griffiths is still unwinding, 5million, 3 million, two at 1.5 million and the share price is still holding 65p. Quite impressive. Must be some broker to broker trades I would guess. Should be an rns tomorrow or monday

[jeanesy] 28/11/2023 17:27

Looks like i will get stopped out tomorrow. Very disappointing as I had high hopes for these ...

[jeanesy] 14/11/2023 10:24

downward trend is continuing sadly.. 60p is close now.